The University of Chicago Header Logo

Connection

Narutoshi Hibino to Blood Vessel Prosthesis

Back to Details
This is a "connection" page, showing publications Narutoshi Hibino has written about Blood Vessel Prosthesis.
Narutoshi Hibino
Connection Strength
10.377
Blood Vessel Prosthesis
  1. Fast-Degrading Tissue-Engineered Vascular Grafts Lead to Increased Extracellular Matrix Cross-Linking Enzyme Expression. Tissue Eng Part A. 2021 11; 27(21-22):1368-1375.
    View in: PubMed
    Score: 0.698
  2. In vivo implantation of 3-dimensional printed customized branched tissue engineered vascular graft in a porcine model. J Thorac Cardiovasc Surg. 2020 05; 159(5):1971-1981.e1.
    View in: PubMed
    Score: 0.613
  3. Bioprinting of freestanding vascular grafts and the regulatory considerations for additively manufactured vascular prostheses. Transl Res. 2019 09; 211:123-138.
    View in: PubMed
    Score: 0.599
  4. Oversized Biodegradable Arterial Grafts Promote Enhanced Neointimal Tissue Formation. Tissue Eng Part A. 2018 08; 24(15-16):1251-1261.
    View in: PubMed
    Score: 0.556
  5. Review of Vascular Graft Studies in Large Animal Models. Tissue Eng Part B Rev. 2018 04; 24(2):133-143.
    View in: PubMed
    Score: 0.539
  6. Bilateral Arteriovenous Shunts as a Method for Evaluating Tissue-Engineered Vascular Grafts in Large Animal Models. Tissue Eng Part C Methods. 2017 11; 23(11):728-735.
    View in: PubMed
    Score: 0.533
  7. Tissue engineered vascular grafts: current state of the field. Expert Rev Med Devices. 2017 May; 14(5):383-392.
    View in: PubMed
    Score: 0.519
  8. Preclinical study of patient-specific cell-free nanofiber tissue-engineered vascular grafts using 3-dimensional printing in a sheep model. J Thorac Cardiovasc Surg. 2017 04; 153(4):924-932.
    View in: PubMed
    Score: 0.502
  9. Tissue-Engineered Small Diameter Arterial Vascular Grafts from Cell-Free Nanofiber PCL/Chitosan Scaffolds in a Sheep Model. PLoS One. 2016; 11(7):e0158555.
    View in: PubMed
    Score: 0.491
  10. Novel Association of miR-451 with the Incidence of TEVG Stenosis in a Murine Model. Tissue Eng Part A. 2016 Jan; 22(1-2):75-82.
    View in: PubMed
    Score: 0.471
  11. The innate immune system contributes to tissue-engineered vascular graft performance. FASEB J. 2015 Jun; 29(6):2431-8.
    View in: PubMed
    Score: 0.445
  12. Evaluation of the use of an induced puripotent stem cell sheet for the construction of tissue-engineered vascular grafts. J Thorac Cardiovasc Surg. 2012 Mar; 143(3):696-703.
    View in: PubMed
    Score: 0.359
  13. A critical role for macrophages in neovessel formation and the development of stenosis in tissue-engineered vascular grafts. FASEB J. 2011 Dec; 25(12):4253-63.
    View in: PubMed
    Score: 0.349
  14. Comparison of human bone marrow mononuclear cell isolation methods for creating tissue-engineered vascular grafts: novel filter system versus traditional density centrifugation method. Tissue Eng Part C Methods. 2011 Oct; 17(10):993-8.
    View in: PubMed
    Score: 0.346
  15. Tissue-engineered vascular grafts form neovessels that arise from regeneration of the adjacent blood vessel. FASEB J. 2011 Aug; 25(8):2731-9.
    View in: PubMed
    Score: 0.342
  16. The tissue-engineered vascular graft using bone marrow without culture. J Thorac Cardiovasc Surg. 2005 May; 129(5):1064-70.
    View in: PubMed
    Score: 0.225
  17. Extruded poly (glycerol sebacate) and polyglycolic acid vascular graft forms a neoartery. J Tissue Eng Regen Med. 2022 04; 16(4):346-354.
    View in: PubMed
    Score: 0.180
  18. Spontaneous reversal of stenosis in tissue-engineered vascular grafts. Sci Transl Med. 2020 04 01; 12(537).
    View in: PubMed
    Score: 0.159
  19. Different degradation rates of nanofiber vascular grafts in small and large animal models. J Tissue Eng Regen Med. 2020 02; 14(2):203-214.
    View in: PubMed
    Score: 0.156
  20. Virtual surgical planning, flow simulation, and 3-dimensional electrospinning of patient-specific grafts to optimize Fontan hemodynamics. J Thorac Cardiovasc Surg. 2018 04; 155(4):1734-1742.
    View in: PubMed
    Score: 0.135
  21. Role of Bone Marrow Mononuclear Cell Seeding for Nanofiber Vascular Grafts. Tissue Eng Part A. 2018 01; 24(1-2):135-144.
    View in: PubMed
    Score: 0.131
  22. In Vitro Endothelialization of Biodegradable Vascular Grafts Via Endothelial Progenitor Cell Seeding and Maturation in a Tubular Perfusion System Bioreactor. Tissue Eng Part C Methods. 2016 07; 22(7):663-70.
    View in: PubMed
    Score: 0.122
  23. Rational design of an improved tissue-engineered vascular graft: determining the optimal cell dose and incubation time. Regen Med. 2016 Mar; 11(2):159-67.
    View in: PubMed
    Score: 0.119
  24. Cilostazol, Not Aspirin, Prevents Stenosis of Bioresorbable Vascular Grafts in a Venous Model. Arterioscler Thromb Vasc Biol. 2015 Sep; 35(9):2003-10.
    View in: PubMed
    Score: 0.114
  25. TGFßR1 inhibition blocks the formation of stenosis in tissue-engineered vascular grafts. J Am Coll Cardiol. 2015 Feb 10; 65(5):512-4.
    View in: PubMed
    Score: 0.111
  26. Contrasting biofunctionalization strategies for the enhanced endothelialization of biodegradable vascular grafts. Biomacromolecules. 2015 Feb 09; 16(2):437-46.
    View in: PubMed
    Score: 0.110
  27. Transplantation of pulmonary valve using a mouse model of heterotopic heart transplantation. J Vis Exp. 2014 Jul 23; (89).
    View in: PubMed
    Score: 0.107
  28. Implantation of inferior vena cava interposition graft in mouse model. J Vis Exp. 2014 Jun 04; (88).
    View in: PubMed
    Score: 0.106
  29. Vessel bioengineering. Circ J. 2014; 78(1):12-9.
    View in: PubMed
    Score: 0.102
  30. Development and assessment of a biodegradable solvent cast polyester fabric small-diameter vascular graft. J Biomed Mater Res A. 2014 Jun; 102(6):1972-1981.
    View in: PubMed
    Score: 0.100
  31. Strategies and techniques to enhance the in situ endothelialization of small-diameter biodegradable polymeric vascular grafts. Tissue Eng Part B Rev. 2013 Aug; 19(4):292-307.
    View in: PubMed
    Score: 0.097
  32. Characterization of the natural history of extracellular matrix production in tissue-engineered vascular grafts during neovessel formation. Cells Tissues Organs. 2012; 195(1-2):60-72.
    View in: PubMed
    Score: 0.088
  33. Determining the fate of seeded cells in venous tissue-engineered vascular grafts using serial MRI. FASEB J. 2011 Dec; 25(12):4150-61.
    View in: PubMed
    Score: 0.087
  34. Vascular tissue engineering: towards the next generation vascular grafts. Adv Drug Deliv Rev. 2011 Apr 30; 63(4-5):312-23.
    View in: PubMed
    Score: 0.085
  35. Tissue-engineered vascular grafts: does cell seeding matter? J Pediatr Surg. 2010 Jun; 45(6):1299-305.
    View in: PubMed
    Score: 0.080
  36. Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling. Proc Natl Acad Sci U S A. 2010 Mar 09; 107(10):4669-74.
    View in: PubMed
    Score: 0.079
  37. Late-term results of tissue-engineered vascular grafts in humans. J Thorac Cardiovasc Surg. 2010 Feb; 139(2):431-6, 436.e1-2.
    View in: PubMed
    Score: 0.078
  38. Tissue-engineered arterial grafts: long-term results after implantation in a small animal model. J Pediatr Surg. 2009 Jun; 44(6):1127-32; discussion 1132-3.
    View in: PubMed
    Score: 0.075
  39. Tissue-engineered vascular grafts demonstrate evidence of growth and development when implanted in a juvenile animal model. Ann Surg. 2008 Sep; 248(3):370-7.
    View in: PubMed
    Score: 0.071
  40. Successful application of tissue engineered vascular autografts: clinical experience. Biomaterials. 2003 Jun; 24(13):2303-8.
    View in: PubMed
    Score: 0.049
  41. Off-the-shelf, heparinized small diameter vascular graft limits acute thrombogenicity in a porcine model. Acta Biomater. 2022 10 01; 151:134-147.
    View in: PubMed
    Score: 0.047
  42. Automatic Shape Optimization of Patient-Specific Tissue Engineered Vascular Grafts for Aortic Coarctation. Annu Int Conf IEEE Eng Med Biol Soc. 2020 07; 2020:2319-2323.
    View in: PubMed
    Score: 0.040
  43. Valve-sparing aortic root replacement in children: Outcomes from 100 consecutive cases. J Thorac Cardiovasc Surg. 2019 03; 157(3):1100-1109.
    View in: PubMed
    Score: 0.036
  44. Aortic Root Replacement for Children With Loeys-Dietz Syndrome. Ann Thorac Surg. 2017 May; 103(5):1513-1518.
    View in: PubMed
    Score: 0.032
  45. TGF-ß receptor 1 inhibition prevents stenosis of tissue-engineered vascular grafts by reducing host mononuclear phagocyte activation. FASEB J. 2016 07; 30(7):2627-36.
    View in: PubMed
    Score: 0.030
  46. 3D-Printed Biodegradable Polymeric Vascular Grafts. Adv Healthc Mater. 2016 Feb 04; 5(3):319-325.
    View in: PubMed
    Score: 0.029
  47. Cell-seeding techniques in vascular tissue engineering. Tissue Eng Part B Rev. 2010 Jun; 16(3):341-50.
    View in: PubMed
    Score: 0.020
  48. Extracardiac total cavopulmonary connection using a tissue-engineered graft. J Thorac Cardiovasc Surg. 2003 Dec; 126(6):1958-62.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.